文献速递中毒与环境急症消化、代谢与肾脏急症

物质使用背景下氨溶液暴露:法国毒物中心数据库2009-2018年回顾性研究

Exposure to ammonia solution due to substance use: a retrospective study from the French poison centres database (2009-2018).
PubMed 文献 · Clin Toxicol (Phila) · 2024-02-28
一句话结论2009-2018年法国已知物质使用者口服/颊部氨溶液暴露增加,多为年轻男性,常与分装及节日场景相关,33%中度、15%重度中毒。

该研究利用法国毒物中心数据库开展10年(2009-2018)回顾性研究,描述物质使用背景下非故意口服及颊部氨溶液暴露的特征。共提取1546份档案,纳入263名物质使用者;2009至2018年间此类暴露数量显著增加。89%的非故意摄入与分装产品相关,25%暴露前有物质使用、21%处于免费派对或 teknivals 等节日场景。87%患者接受医院检查,按中毒严重度评分33%为中度、15%为重度。作者认为氨溶液暴露可提示物质使用障碍可能,此类患者可转诊接受适当治疗与支持。

要点

  • 2009-2018年法国毒物中心数据库中物质使用者口服/颊部氨溶液暴露数量显著增加,共纳入263名物质使用者。
  • 89%的非故意摄入与分装氨溶液产品相关,25%暴露前有物质使用、21%处于免费派对或 teknivals 等节日场景。
  • 87%患者接受医院检查,按中毒严重度评分33%为中度、15%为重度中毒。
  • 作者认为氨溶液暴露可提示物质使用障碍可能,此类患者可转诊接受适当治疗与支持。
  • 作者指出物质使用者口服或颊部氨溶液暴露的潜在严重性需要所有参与此类中毒管理的医疗专业人员提高警惕。

适用人群与场景

  • 法国毒物中心数据库中2009-2018年间非故意口服及颊部氨溶液暴露的已知物质使用者,共263名,多为年轻男性。
  • 暴露场景包括免费派对或 teknivals 等节日场景(21%),25%病例暴露前有物质使用。

诊断标准与关键阈值

  • 中毒严重度采用中毒严重度评分(Poisoning Severity Score)分级,物质使用者中33%为中度、15%为重度。

红旗征与不能漏的情况

  • 作者指出物质使用者口服或颊部氨溶液暴露具有潜在严重性,需要所有参与此类中毒管理的医疗专业人员提高警惕。

研究设计与关键结果

  • 研究为基于法国毒物中心数据库的回顾性研究,覆盖2009-2018年10年期间,共提取1546份档案,最终纳入263名物质使用者。
  • 2009至2018年间此类暴露数量显著增加。
  • 非故意摄入氨溶液89%与分装产品相关;25%病例暴露前有物质使用,21%处于免费派对或 teknivals 等节日场景。
  • 87%患者接受医院检查;按中毒严重度评分,33%为中度、15%为重度。
  • 作者认为氨溶液暴露增加与同期欧洲快克可卡因使用者数量增加一致。

证据类型、等级与局限

  • 证据类型:基于法国毒物中心数据库的回顾性研究。
  • 局限:回顾性研究导致可用信息缺乏,且毒物中心医学电话访谈中所提问题非标准化。

对床旁实践的改变

  • 作者认为氨溶液暴露可提示物质使用障碍的可能,在此类情况下患者可转诊接受适当治疗与支持。
  • 作者指出物质使用者口服或颊部氨溶液暴露的潜在严重性需要所有参与此类中毒管理的医疗专业人员提高警惕。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Ammonia solution (ammonium hydroxide) is used to convert cocaine hydrochloride to freebase cocaine. Due to its causticity, unintentional exposure to ammonia in a substance use context can result in injury. The objective of this study was to describe the characteristics of unintentional oral and buccal ammonia solution exposure in a substance use context.

METHODS: A retrospective study was conducted using the French poison centres database over a 10-year period (2009-2018).

RESULTS: A total of 1,546 files were extracted, and 263 substance users were included. There was a significant increase in the number of these exposures between 2009 and 2018. Unintentional ingestion of ammonia solution was linked to product decanting in 89 per cent of cases. Substance use prior to the exposure and a festive context, such as free parties or teknivals, were identified in 25 per cent and 21 per cent of cases, respectively. Patients received a hospital examination in 87 per cent of cases. The severity of intoxication in substance users was graded as moderate (33 per cent) or severe (15 per cent) using the Poisoning Severity Score.

DISCUSSION: The increased number of ammonia solution cases reported was consistent with an increase in the number of crack users in Europe in the same period. Ammonia solution exposure can suggest the possibility of substance use disorders. In such cases, patients can be referred to receive appropriate treatment and support. This study had some limitations, such as the lack of available information due to the retrospective nature of the study and the non-standardized questions asked by the poison centre during the medical phone interviews.

CONCLUSION: Oral and buccal ammonia solution exposure in known substance users in France increased between 2009 and 2018. These users were mostly young men. A festive context and decanting were frequent. Patients were mainly referred to emergency departments to receive clinical examination and care. The potential severity of oral or buccal ammonia solution exposure in substance users requires increased vigilance among all healthcare professionals involved in the management of these intoxication cases.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Czerwiec A, Chevallier C, Grenet G, et al. Exposure to ammonia solution due to substance use: a retrospective study from the French poison centres database (2009-2018). Clin Toxicol (Phila). 2024. PMID: 38416057. doi:10.1080/15563650.2024.2313088

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。